Oramed Pharmaceuticals annual free cash flow per share
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Oramed Pharmaceuticals Free Cash Flow Per Share Growth & History (ORMP)
Oramed Pharmaceuticals's free cash flow per share was -$0.22 for fiscal 2025.
View full Oramed Pharmaceuticals company overviewOramed Pharmaceuticals annual free cash flow per share history
| Fiscal year | Period ended | Free cash flow per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | -$0.22 | -$0.01 | — |
| 2024 | 2024-12-31 | -$0.21 | $0.06 | — |
| 2023 | 2023-12-31 | -$0.26 | $0.47 | — |
| 2022 | 2022-12-31 | -$0.73 | — | — |
| 2021 | 2021-08-31 | -$0.76 | -$0.15 | — |
| 2020 | 2020-08-31 | -$0.61 | $0.13 | — |
| 2019 | 2019-08-31 | -$0.74 | $0.24 | — |
| 2018 | 2018-08-31 | -$0.99 | -$0.55 | — |
| 2017 | 2017-08-31 | -$0.44 | -$0.81 | — |
| 2016 | 2016-08-31 | $0.37 | $0.83 | — |
| 2015 | 2015-08-31 | -$0.46 | -$0.02 | — |
| 2014 | 2014-08-31 | -$0.44 | $0.03 | — |
| 2013 | 2013-08-31 | -$0.47 | -$0.08 | — |
| 2012 | 2012-08-31 | -$0.39 | — | — |
Oramed Pharmaceuticals quarterly free cash flow per share
Q3.12
Q1.14
Q2.14
Q3.14
Q1.15
Q2.15
Q3.15
Q1.16
Q2.16
Q3.16
Q3.17
Q3.18
Q1.19
Q2.19
Q3.19
Q1.20
Q2.20
Q3.20
Q1.21
Q1.21
Q2.21
Q2.21
Q3.21
Q3.21
Q3.22
Q2.22
Q3.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Free cash flow per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | -$0.00 | $0.08 | — |
| Q1 2026 | 2026-03-31 | -$0.07 | $0.01 | — |
| Q3 2025 | 2025-09-30 | -$0.04 | $0.13 | — |
| Q2 2025 | 2025-06-30 | -$0.08 | -$0.14 | — |
| Q1 2025 | 2025-03-31 | -$0.09 | -$0.05 | — |
| Q3 2024 | 2024-09-30 | -$0.17 | -$0.16 | — |
| Q2 2024 | 2024-06-30 | $0.05 | $0.12 | — |
| Q1 2024 | 2024-03-31 | -$0.04 | $0.11 | — |
| Q3 2023 | 2023-09-30 | -$0.02 | $0.04 | — |
| Q2 2023 | 2023-06-30 | -$0.07 | $0.15 | — |
| Q1 2023 | 2023-03-31 | -$0.14 | $0.09 | — |
| Q3 2022 · Sep 30 | 2022-09-30 | -$0.06 | $0.10 | — |
| Q3 2022 · Jun 30 | 2022-06-30 | -$0.22 | -$0.07 | — |
| Q2 2022 | 2022-03-31 | -$0.24 | -$0.10 | — |
| Q3 2022 · Sep 30 | 2021-09-30 | -$0.16 | — | — |
| Q3 2021 · Jun 30 | 2021-06-30 | -$0.15 | — | — |
| Q3 2021 · May 31 | 2021-05-31 | -$0.19 | -$0.04 | — |
| Q2 2021 · Mar 31 | 2021-03-31 | -$0.13 | — | — |
| Q2 2021 · Feb 28 | 2021-02-28 | -$0.04 | $0.16 | — |
| Q1 2021 · Dec 31 | 2020-12-31 | -$0.08 | — | — |
| Q1 2021 · Nov 30 | 2020-11-30 | -$0.27 | -$0.10 | — |
| Q3 2020 | 2020-05-31 | -$0.14 | $0.07 | — |
| Q2 2020 | 2020-02-29 | -$0.20 | -$0.10 | — |
| Q1 2020 | 2019-11-30 | -$0.17 | $0.07 | — |
| Q3 2019 | 2019-05-31 | -$0.21 | $0.05 | — |
| Q2 2019 | 2019-02-28 | -$0.11 | — | — |
| Q1 2019 | 2018-11-30 | -$0.24 | — | — |
| Q3 2018 | 2018-05-31 | -$0.26 | -$0.08 | — |
| Q3 2017 | 2017-05-31 | -$0.18 | -$0.01 | — |
| Q3 2016 | 2016-05-31 | -$0.17 | -$0.09 | — |
| Q2 2016 | 2016-02-29 | $0.18 | $0.33 | — |
| Q1 2016 | 2015-11-30 | -$0.19 | -$0.06 | — |
| Q3 2015 | 2015-05-31 | -$0.08 | $0.02 | — |
| Q2 2015 | 2015-02-28 | -$0.15 | $0.01 | — |
| Q1 2015 | 2014-11-30 | -$0.14 | -$0.04 | — |
| Q3 2014 | 2014-05-31 | -$0.11 | — | — |
| Q2 2014 | 2014-02-28 | -$0.16 | — | — |
| Q1 2014 | 2013-11-30 | -$0.09 | — | — |
| Q3 2012 | 2012-05-31 | -$0.15 | — | — |
Oramed Pharmaceuticals free cash flow per share trends
Between the periods ended 2012-08-31 and 2025-12-31, Oramed Pharmaceuticals's free cash flow per share increased from -$0.39 to -$0.22, a change of $0.17. The latest reported quarter, Q2 2026, shows -$0.00.
About the metric
What free cash flow per share means
Free cash flow per share estimates the free cash flow generated for each weighted-average common share. It combines operating cash generation, capital spending, and the share base into a per-share measure that can be compared over time.
Calculation and source
How free cash flow per share is calculated
TickerStat calculates free cash flow as operating cash flow minus capital expenditures, then divides it by basic weighted-average shares for the aligned fiscal period. Reliable filing-derived share counts are used when a filer omits the direct weighted-average-share fact. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Oramed Pharmaceuticals source filings ↗